Skip to main content
. 2018 Jul 9;32(11):1710–1716. doi: 10.1038/s41433-018-0165-5

Table 2.

Success rate of SLT

At 6 months (n = 33) At 1 year (n = 28)
n (% eyes)
(with medicines)
n (% eyes)
(without medicines)
n (% eyes)
(with medicines)
n (% eyes)
(without medicines)
IOP reduction
≥4 mm Hg 28 (84.84) 24 (72.72) 23 (82.15) 16 (57.14)
≥6 mm Hg 19 (57.57) 16 (48.48) 19 (67.85) 13 (46.42)
≥20% 20 (60.60) 17 (51.51) 19 (67.85) 13 (46.42)
≥25% 14 (42.42) 12 (36.36) 18 (64.28) 11 (39.28)
IOP
<12 mm Hg
12–15 mm Hg 2 (6.00) 3 (9.00) 4 (14.28) 10 (35.70)
16–18 mm Hg 15 (45.45) 17 (51.52) 7 (25.00) 11 (39.28)
19–21 mm Hg 10 (30.30) 10 (30.30) 6 (21.43) 6 (21.42)
>21 mm Hg 2 (6.00) 3 (9.00) 1 (3.60) 1 (3.60)

IOP intraocular pressure